Publications
5491 Results
- Journal / Conference
- Gastroenterology Mar;160(4):1164-1178.e6. doi: 10.1053/j.gastro.2020.08.062. Epub 2020 Oct 12.
- Year
- 2021
- Research Committee(s)
- Prevention and Epidemiology
- PMID
- PMID33058866
- PMC
- PMC7956223
- Study Number(s)
- S0000
Identifying novel susceptibility genes for colorectal cancer risk from a transcriptome-wide association study of 125,478 subjects
- Journal / Conference
- J Clin Oncol 39, 2021 (suppl 3; abstr 419); ASCO GI Cancers Symposium (January 15-17, 2021, virtual), oral
- Year
- 2021
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/A021501
Alliance trial A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the pancreas
- Journal / Conference
- J Clin Oncol 39, 2021 (suppl 3; abstr 419); ASCO GI Cancers Symposium (January 15-17, 2021, virtual), Poster Presentation and Poster Highlights session
- Year
- 2021
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S1505
Immunologic Predictors of Therapeutic Response to Neoadjuvant Therapy for Pancreatic Adenocarcinoma (PDA) in SWOG S1505
- Journal / Conference
- J Clin Oncol 39, 2021 (suppl 3; abstr TPS447); ASCO GI Cancers Symposium (January 15-17, 2021, virtual), poster session
- Year
- 2021
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S2001
S2001: Randomized Phase II Clinical Trial of Olaparib + Pembrolizumab vs. Olaparib Alone as Maintenance Therapy in Metastatic Pancreatic Cancer Patients with Germline BRCA1 or BRCA2 Mutations
- Journal / Conference
- J Clin Oncol 39, 2021 (suppl 3; abstr 10); ASCO GI Cancers Symposium (January 15-17, 2021, virtual), rapid abstract presentation (oral)
- Year
- 2021
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/C80702
Prognostic value of tumor deposits in stage III colon cancer patients, a post hoc analysis of CALGB/SWOG 80702 phase III study
- Journal / Conference
- J Clin Oncol 39, 2021 (suppl 3; abstr 361); ASCO GI Cancers Symposium (January 15-17, 2021, virtual), poster
- Year
- 2021
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/A021202
Discordance between central vs. local response assessments in neuroendocrine tumor (NET) patients enrolled in A021202
- Journal / Conference
- J Clin Oncol 39, 2021 (suppl 3; abstr TPS158); ASCO GI Cancers Symposium (January 15-17, 2021, virtual), TIPS, poster
- Year
- 2021
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/NRG-GI004
NRG-GI004/SWOG-S1610: Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study: A randomized phase III study of atezolizumab (atezo) monotherapy versus mFOLFOX6/bevacizumab/atezo in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) or microsatellite instability high (MSI-H) metastatic colorectal cancer (mCRC)
- Journal / Conference
- Leukemia and Lymphoma Jul;62(7):1774-1777
- Year
- 2021
- Research Committee(s)
- Leukemia
- PMID
- PMID33560164
- PMC
- PMC8282671
- Study Number(s)
- S0106, S1203
Predicting Severe Toxicities with Intensive Induction Chemotherapy for Adult Acute Myeloid Leukemia: Analysis of SWOG Trials S0106 and S1203
- Journal / Conference
- JCO Oncology Practice
- Year
- 2021
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID33534616
- PMC
- PMC8791825
Moving Beyond the Momentum: Innovative Approaches to Clinical Trial Implementation [Care Delivery Review]
- Journal / Conference
- Clinical Lung Cancer May;22(3):187-194.e1. doi: 10.1016/j.cllc.2021.01.001. Epub 2021 Jan 10.
- Year
- 2021
- Research Committee(s)
- Lung
- PMID
- PMID33583720
- Study Number(s)
- S1400G